My watch list
my.bionity.com  
Login  
NEWS
Current news

Sartorius continues on its dynamic growth track

21-Oct-2019 Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the ye ... more

Sartorius signs agreement to acquire select Danaher Life Science platform businesses

21-Oct-2019 Sartorius has signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-Digit profit margins. They employ around 30 ... more

Immune reaction causes malaria organ damage

Immune cells can be the body's defenders and foes at the same time

21-Oct-2019 Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of th ... more

The recipe for making a fruit fly

Scientists use mass spectrometry to determine the absolute copy number of nuclear proteins and histone marks

21-Oct-2019 Currently, most if not all of the proteins that are required for constructing a multicellular organism are known. However, it is largely unclear how many copies of each protein species are present and needed to permit an animal to develop into a complete organism. Researchers at the Max Pla ... more

Merck Launches Seed Fund for Startups in China

RMB 100 million fund targets startups close to the three business sectors of Merck as well as new businesses

21-Oct-2019 Merck announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced plans to officially open a second innovation hub in Guangzhou in November. “Our RMB 100 million China seed fund underlin ... more

Aҫaí berry extracts fight malaria in mice

18-Oct-2019 Despite humanity's best efforts to eradicate malaria, the disease struck more than 200 million people in 2017, according to the World Health Organization. Worse yet, the parasite that causes malaria is developing resistance to many antimalarial drugs, including the mainstay, chloroquine. Re ... more

Computational 'match game' identifies potential antibiotics

Software tool speeds discovery using microbial datasets

18-Oct-2019 Computational biologists at Carnegie Mellon University have devised a software tool that can play a high-speed "Match Game" to identify bioactive molecules and the microbial genes that produce them so they can be evaluated as possible antibiotics and other therapeutic agents. Working with c ... more

Scientists work toward a rapid point-of-care diagnostic test for Lyme disease

18-Oct-2019 A study published in the Journal of Clinical Microbiology describes a new rapid assay for Lyme disease that could lead to a practical test for use by healthcare providers. The researchers found the assay, which uses several biomarkers to detect Lyme disease infection, was more sensitive tha ... more

Protein misfolding as a risk marker for Alzheimer’s disease – up to 14 years before the diagnosis

17-Oct-2019 In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicated a considerably higher risk of Alzheimer's disease – up to 14 years before a clinical diagnosis was made. Amyloid-β folding proved to be superior to other risk markers evaluated, as shown by scie ... more

€12M Series A Financing to Develop Novel Immuno-Virotherapies Against Cancer

17-Oct-2019 Abalos Therapeutics announced a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutics based on a specific arenavirus strain that preferentially infects and proliferates in cancer cells gener ... more

All news

Sartorius continues on its dynamic growth track

21-Oct-2019 Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the ye ... more

Sartorius signs agreement to acquire select Danaher Life Science platform businesses

21-Oct-2019 Sartorius has signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-Digit profit margins. They employ around 30 ... more

Improving research with more effective antibodies

Scientists demonstrate flaws in protein detection tools, and outline a solution

17-Oct-2019 A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly. Antibodies are used in laboratories and clinics to study proteins, which are the biomolecules that translate informatio ... more

QIAGEN announces CEO leadership transition

Peer M. Schatz to step down as CEO

08-Oct-2019 QIAGEN N.V. announced that Peer M. Schatz, Chief Executive Officer, has notified the Company that, after 27 years at QIAGEN, he has decided to step down as Chief Executive Officer and Chairman of the Management Board. He will remain with QIAGEN as Special Advisor to the Supervisory Board an ... more

FLAM-seq: the full picture of messenger RNA and their tails

19-Aug-2019 Researchers in MDC’s Berlin Institute for Medical Systems Biology (BIMSB) have developed a tool enabling accurate sequencing of messenger RNA along with their tails for the first time. Professor Nikolaus Rajewsky and his team described this new tool, called full-length poly(A) and mRNA sequ ... more

Using quantum dots and a smartphone to find killer bacteria

Scientists develop cheap and rapid way to identify antibiotic-resistant golden staph (MRSA)

19-Aug-2019 A combination of off-the-shelf quantum dot nanotechnology and a smartphone camera soon could allow doctors to identify antibiotic-resistant bacteria in just 40 minutes, potentially saving patient lives. Staphylococcus aureus (golden staph), is a common form of bacterium that causes serious ... more

Team of researchers in Vienna has decoded the structure of the ribonucleoprotein (RNP) of rabies virus

02-Aug-2019 A research team of the Institute of Virology of the University of Veterinary Medicine Vienna has achieved a major breakthrough in exploring the rabies virus: for the first time, researchers were able to exactly depict the structure of the RNP of this virus that is highly dangerous to terres ... more

New, portable tech sniffs out plant disease in the field

01-Aug-2019 Researchers at North Carolina State University have developed portable technology that allows farmers to identify plant diseases in the field. The handheld device, which is plugged into a smartphone, works by sampling the airborne volatile organic compounds (VOCs) that plants release throug ... more

For salmonella detection, genomic tool emerges as a key

31-Jul-2019 The world's food supply will become safer as the food industry shifts to high-resolution, whole-genome sequencing - which examines the full DNA of a given organism all at once. This move to make sequencing ubiquitous will lead to the consistently reliable detection of salmonella. A paper pu ... more

Listening to the whispers of individual cells

30-Jul-2019 For the cells in our bodies to function as a unit, they must communicate with one another constantly. They secrete signalling molecules – ions, proteins and nucleic acids – that are picked up by adjacent cells, which in turn pass on the signal to other cells. Our muscles, digestive system a ... more

All news on bioanalytics

Sartorius continues on its dynamic growth track

21-Oct-2019 Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the ye ... more

Sartorius signs agreement to acquire select Danaher Life Science platform businesses

21-Oct-2019 Sartorius has signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-Digit profit margins. They employ around 30 ... more

Merck Launches Seed Fund for Startups in China

RMB 100 million fund targets startups close to the three business sectors of Merck as well as new businesses

21-Oct-2019 Merck announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced plans to officially open a second innovation hub in Guangzhou in November. “Our RMB 100 million China seed fund underlin ... more

€12M Series A Financing to Develop Novel Immuno-Virotherapies Against Cancer

17-Oct-2019 Abalos Therapeutics announced a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutics based on a specific arenavirus strain that preferentially infects and proliferates in cancer cells gener ... more

CO2 for a clean performance: Rheticus research project by Evonik and Siemens enters phase 2

High-value specialty chemicals produced from CO2 and water using electricity from renewable sources and bacteria

14-Oct-2019 Evonik and Siemens launched their joint research project Rheticus II. The goal is to develop an efficient and powerful test plant that will use carbon dioxide and water as well as electricity from renewable sources and bacteria to produce specialty chemicals (CO2). In the Rheticus I project ... more

Create blood vessels using patient’s own cells

Vacis raises capital from Brightlands Venture Partners, HTGF, LIOF and RVO

14-Oct-2019 Every year, an estimated 300.000 hemodialysis patients worldwide die as they run out of medical alternatives. One of the main reasons for these deaths is failure of the vascular access site, the blood vessel where blood is removed, filtered and returned to the body during dialysis. To solve ... more

Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing

Acquisition of FloDesign Sonics marks next step in autologous manufacturing

11-Oct-2019 Merck announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed. “Chimeric antigen receptor T cell therapies, or ... more

A new strategy for the synthesis of complex natural products

11-Oct-2019 Chemists from the University of Basel have succeeded in synthesizing two complex natural products from the group of dithiodiketopiperazines (DTPs). For this, they employed a new strategy based on “C-H bond activation,” resulting in a short and high yielding route. In the of the Journal of t ... more

How to make biocatalysts immortal

10-Oct-2019 Oxygen threatens sustainable catalysts that use hydrogen to produce electricity in fuel cells. Researchers from Bochum and Marseille have developed a way to combat this. Efficient catalysts for converting hydrogen into electricity in fuel cells for the energy transition are often based on e ... more

Spider silk: A malleable protein provides reinforcement

30-Sep-2019 Scientists from the University of Würzburg have discovered that spider silk contains an exceptional protein. It generates high bonding strength by making use of an amino acid scientists have hitherto paid little attention to. The finding could have important implications in many areas. Why ... more

All news on biotechnology

Scientists work toward a rapid point-of-care diagnostic test for Lyme disease

18-Oct-2019 A study published in the Journal of Clinical Microbiology describes a new rapid assay for Lyme disease that could lead to a practical test for use by healthcare providers. The researchers found the assay, which uses several biomarkers to detect Lyme disease infection, was more sensitive tha ... more

Protein misfolding as a risk marker for Alzheimer’s disease – up to 14 years before the diagnosis

17-Oct-2019 In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicated a considerably higher risk of Alzheimer's disease – up to 14 years before a clinical diagnosis was made. Amyloid-β folding proved to be superior to other risk markers evaluated, as shown by scie ... more

Diagnostics for everyone

Researchers present a cost-effective machine for the production of microarrays

16-Oct-2019 Microarrays are state-of-the-art tools in molecular biology that enable the rapid and parallel diagnosis of various diseases. Therefore, they are indispensable for the development of new vaccines. Like a computer chip, microarrays contain a lot of information in the smallest space. Microarr ... more

Blood test raises hopes of tackling 'silent killer'

15-Oct-2019 It is the 'silent killer' that claimed the life of Albert Einstein and affects 1% of men over the age of 65, but researchers at the University of Dundee believe they may be able to reduce the number of fatalities caused by abdominal aortic aneurysms. Aneurysms are the swelling and weakening ... more

Wood on our Skin

Flexible, biocompatible nanocellulose sensors

10-Oct-2019 Physiological parameters in our blood can be determined without painful punctures. Empa researchers are currently working with a Canadian team to develop flexible, biocompatible nanocellulose sensors that can be attached to the skin. The 3D-printed analytic chips made of renewable raw mater ... more

QIAGEN announces CEO leadership transition

Peer M. Schatz to step down as CEO

08-Oct-2019 QIAGEN N.V. announced that Peer M. Schatz, Chief Executive Officer, has notified the Company that, after 27 years at QIAGEN, he has decided to step down as Chief Executive Officer and Chairman of the Management Board. He will remain with QIAGEN as Special Advisor to the Supervisory Board an ... more

Inspired by nature: Scientists have developed a nanopore-microchip

01-Oct-2019 Medical professionals and environment analysts would like to have microchips that measure substances directly on site. Scientists at TU Darmstadt have developed and patented a system based on nanopores with broad potential. Anyone wishing to use laboratory readings for diagnosing a disorder ... more

Artificial intelligence improves biomedical imaging

01-Oct-2019 ETH researchers use artificial intelligence to improve quality of images recorded by a relatively new biomedical imaging method. This paves the way towards more accurate diagnosis and cost-effective devices. Scientists at ETH Zurich and the University of Zurich have used machine learning me ... more

Measuring ethanol’s deadly twin

18-Sep-2019 ETH researchers have developed an inexpensive, handheld measuring device that can distinguish between methanol and potable alcohol. It offers a simple, quick method of detecting adulterated or contaminated alcoholic beverages and is able to diagnose methanol poisoning in exhaled breath. Met ... more

Machine learning improves cancer diagnosis

16-Sep-2019 Researchers from Charité – Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have successfully solved a longstanding problem in the diagnosis of head and neck cancers. Working alongside colleagues from Technische Universität (TU) Berlin, the researchers used artificial inte ... more

All news on diagnostics

Sartorius continues on its dynamic growth track

21-Oct-2019 Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the ye ... more

Sartorius signs agreement to acquire select Danaher Life Science platform businesses

21-Oct-2019 Sartorius has signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-Digit profit margins. They employ around 30 ... more

Eppendorf significantly expands production site in Oldenburg

27-Sep-2019 The Eppendorf Group is boosting its production capacity at its site in Oldenburg in Holstein by building two new production halls. Operations at the two sites will begin in the second half of 2020, significantly increasing the overall capacity of Eppendorf Polymere GmbH, a wholly owned subs ... more

ZEISS Opts for Continuity with New CEO

25-Sep-2019 At its meeting on 24 September 2019, the Supervisory Board of Carl Zeiss AG unanimously voted in favor of the following changes to the Executive Board: Dr. Karl Lamprecht, currently a Member of the Executive Board, will become the new President & CEO effective 1 April 2020. With this appoin ... more

New sample holder for protein crystallography

20-Sep-2019 An HZB research team has developed a novel sample holder that considerably facilitates the preparation of protein crystals for structural analysis. A short video by the team shows how proteins in solution can be crystallised directly onto the new sample holders themselves, then analysed usi ... more

Machine learning algorithm can't distinguish these lab mini-brains from preemie babies

03-Sep-2019 Brain organoids -- also called mini-brains -- are 3D cellular models that represent aspects of the human brain in the laboratory. Brain organoids help researchers track human development, unravel the molecular events that lead to disease and test new treatments. They aren't prefect replicas ... more

Merck Acquires laboratory informatics company

07-Aug-2019 Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving. Financial details were not disclosed. “BSSN Software and the capabilities that it bri ... more

First trade fair in the analytica network in Africa

Successful premiere for analytica Lab Africa

17-Jul-2019 The first analytica Lab Africa took place from July 09 to 11, 2019, at the Gallagher Convention Center in Johannesburg: 148 exhibitors from 15 countries presented their tailor-made solutions from laboratory technology, analysis, biotechnology and diagnostics for the African market. analytic ... more

Sanofi and Google to develop new healthcare Innovation Lab

20-Jun-2019 Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping into the power of emerging data technologies. “We stand on the forefront of a new age for biology and human health, with t ... more

A rapid, easy-to-use DNA amplification method at 37°C

Study could advance molecular diagnosis and robotics

17-Jun-2019 Scientists in Japan have developed a way of amplifying DNA on a scale suitable for use in the emerging fields of DNA-based computing and molecular robotics. By enabling highly sensitive nucleic acid detection, their method could improve disease diagnostics and accelerate the development of ... more

All news on lab technology

€12M Series A Financing to Develop Novel Immuno-Virotherapies Against Cancer

17-Oct-2019 Abalos Therapeutics announced a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutics based on a specific arenavirus strain that preferentially infects and proliferates in cancer cells gener ... more

Evotec and Celmatix enter into strategic collaboration

10-Oct-2019 Evotec SE and Celmatix Inc., a precision medicine company with a proprietary multi-omics platform, announced a partnership to develop pre-clinical programmes in prevalent but underserved conditions affecting women’s reproductive health, including polycystic ovary syndrome (“PCOS”), endometr ... more

Deep learning, prefabricated

09-Oct-2019 Self-driving cars, the automatic detection of cancer cells, online translation: deep learning makes it all possible. The ETH spin-off Mirage Technologies has developed a deep learning platform that aims to help start-ups and companies more quickly develop and optimise their products. The na ... more

BASF and Biomillenia join forces in microbiome research

08-Oct-2019 BASF and Biomillenia announced the signing of a microbiome discovery agreement. The collaboration aims to identify novel dermocosmetic active ingredients involved in promoting skin health. The French company Biomillenia will contribute its unique microbiome-on-a-chip technology that has the ... more

Evotec reaches milestone in integrated drug discovery and development partnership with Aeovian

07-Oct-2019 Evotec SE announced that the Company has reached a milestone in a drug discovery and development partnership with the biopharmaceutical company Aeovian Pharmaceuticals, Inc. Aeovian and Evotec entered into a drug discovery partnership in 2017 to discover and develop new and highly selective ... more

Chemicals for pharmaceuticals could be made cheaper and greener by new catalysts

04-Oct-2019 High value chemicals used to make pharmaceuticals could be made much cheaper and quicker thanks to a series of new catalysts made by scientists at the University of Warwick in collaboration with GoldenKeys High-Tech Co., Ltd. in China. The process of making high-value chemicals for uses suc ... more

Scientists come up with faster way to discover antibiotics

02-Oct-2019 Russian biochemists have identified a promising new class of antibiotics. Having studied over 125,000 molecules, they found that 2-pyrazol-1-yl-thiazole derivatives exhibit antibacterial properties. One of the discovered compounds has demonstrated a good activity and low cytotoxicity, and t ... more

Evotec and Indivumed achieve milestone in joint strategic drug discovery collaboration

30-Sep-2019 Evotec SE and Indivumed GmbH announced that the first milestone has been successfully achieved in their joint collaboration to identify new therapeutic targets for the treatment of colorectal cancer. Under the terms of the collaboration agreement, Evotec received full access to the colorect ... more

€7 Million to Generate First in Class Anti-TACA Antibodies for Cancer Treatment

26-Sep-2019 Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announced that it has successfully secured €7 million in seed funding. The funding round involves a syndicate of leading European life science an ... more

Evotec and Takeda enter collaboration agreement to discover clinical candidates across multiple therapeutic areas

24-Sep-2019 Evotec SE announced a strategic, multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Under the collaboration, the parties aim to establish at least five drug discovery programmes with the goal of Evotec delivering clinical candidates for Takeda to pursue into ... more

All news on pharma

Immune reaction causes malaria organ damage

Immune cells can be the body's defenders and foes at the same time

21-Oct-2019 Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of th ... more

Merck Launches Seed Fund for Startups in China

RMB 100 million fund targets startups close to the three business sectors of Merck as well as new businesses

21-Oct-2019 Merck announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced plans to officially open a second innovation hub in Guangzhou in November. “Our RMB 100 million China seed fund underlin ... more

Aҫaí berry extracts fight malaria in mice

18-Oct-2019 Despite humanity's best efforts to eradicate malaria, the disease struck more than 200 million people in 2017, according to the World Health Organization. Worse yet, the parasite that causes malaria is developing resistance to many antimalarial drugs, including the mainstay, chloroquine. Re ... more

Computational 'match game' identifies potential antibiotics

Software tool speeds discovery using microbial datasets

18-Oct-2019 Computational biologists at Carnegie Mellon University have devised a software tool that can play a high-speed "Match Game" to identify bioactive molecules and the microbial genes that produce them so they can be evaluated as possible antibiotics and other therapeutic agents. Working with c ... more

Protein misfolding as a risk marker for Alzheimer’s disease – up to 14 years before the diagnosis

17-Oct-2019 In symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicated a considerably higher risk of Alzheimer's disease – up to 14 years before a clinical diagnosis was made. Amyloid-β folding proved to be superior to other risk markers evaluated, as shown by scie ... more

Cancer: Inactive receptor renders immunotherapies ineffective

Important reason for poor response to checkpoint inhibitors identified

16-Oct-2019 The aim of immunotherapies is to enable the immune system once again to fight cancer on its own. Drugs known as checkpoint inhibitors are already in clinical use for this purpose. However, they are only effective in about one third of patients. Based on analysis of human tissue samples, a t ... more

Shipment tracking for "fat parcels" in the body

Researchers show that highly sensitive method can "track" lipid metabolism

16-Oct-2019 Without fat, nothing works in the body: These substances serve as energy suppliers and important building blocks - including for the envelopes of living cells. Numerous diseases are related to disorders in the fat metabolism, such as obesity or cancer. Researchers from the LIMES Institute a ... more

Chronobiology: Sleep and synaptic rhythms

15-Oct-2019 Chronobiologists at Ludwig-Maximilians-Universität (LMU) in Munich, Germany, show in two articles in the journal Science how critical the sleep-wake cycle is for protein and phosphorylation dynamics in synapses to ultimately regulate its activity. The internal clock controls virtually all p ... more

New method for quicker and simpler production of lipidated proteins

15-Oct-2019 Some of the body’s proteins are not just made up of amino acids, they are also ‘decorated’ with lipid chains, which significantly influence the biological functions of the protein. An example is the Ras protein, which plays a role in the development of many types of cancers and is only acti ... more

Blood test raises hopes of tackling 'silent killer'

15-Oct-2019 It is the 'silent killer' that claimed the life of Albert Einstein and affects 1% of men over the age of 65, but researchers at the University of Dundee believe they may be able to reduce the number of fatalities caused by abdominal aortic aneurysms. Aneurysms are the swelling and weakening ... more

All news on healthcare
News by department
  • Products

    Using algorithms to track down cancer

    08-Aug-2019 Modern medicine is looking for markers that provide early warning of complex diseases. In its quest to discover these “biomarkers”, the ETH spinoff Scailyte has developed software capable of analysing millions of single cells very efficiently. The search for biomarkers is currently one of t ... more

    Nordic Nanovector: European Patent Granted for Betalutin or Humalutin in Combination With Anti-CD20 Antibodies for Treating NHL

    04-Jun-2019 Nordic Nanovector ASA announces that the European Patent Organisation (EPO) has granted the company's European Patent covering the use of Betalutin® or Humalutin® in combination with anti-CD20 antibodies for the treatment of non-Hodgkin's lymphoma (NHL). The same patent has also been issued ... more

    Merck and Pfizer receive FDA approval for kidney cancer therapy

    BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma

    15-May-2019 Merck and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of patients with advanced renal cell carcinoma (RCC). This is the first FDA approval for an anti-PD-L1 therapy as part o ... more

  • Business

    Sartorius signs agreement to acquire select Danaher Life Science platform businesses

    21-Oct-2019 Sartorius has signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-Digit profit margins. They employ around 30 ... more

    Merck Launches Seed Fund for Startups in China

    RMB 100 million fund targets startups close to the three business sectors of Merck as well as new businesses

    21-Oct-2019 Merck announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced plans to officially open a second innovation hub in Guangzhou in November. “Our RMB 100 million China seed fund underlin ... more

    Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing

    Acquisition of FloDesign Sonics marks next step in autologous manufacturing

    11-Oct-2019 Merck announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed. “Chimeric antigen receptor T cell therapies, or ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Immune reaction causes malaria organ damage

    Immune cells can be the body's defenders and foes at the same time

    21-Oct-2019 Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of th ... more

    The recipe for making a fruit fly

    Scientists use mass spectrometry to determine the absolute copy number of nuclear proteins and histone marks

    21-Oct-2019 Currently, most if not all of the proteins that are required for constructing a multicellular organism are known. However, it is largely unclear how many copies of each protein species are present and needed to permit an animal to develop into a complete organism. Researchers at the Max Pla ... more

    Aҫaí berry extracts fight malaria in mice

    18-Oct-2019 Despite humanity's best efforts to eradicate malaria, the disease struck more than 200 million people in 2017, according to the World Health Organization. Worse yet, the parasite that causes malaria is developing resistance to many antimalarial drugs, including the mainstay, chloroquine. Re ... more

  • People

    QIAGEN announces CEO leadership transition

    Peer M. Schatz to step down as CEO

    08-Oct-2019 QIAGEN N.V. announced that Peer M. Schatz, Chief Executive Officer, has notified the Company that, after 27 years at QIAGEN, he has decided to step down as Chief Executive Officer and Chairman of the Management Board. He will remain with QIAGEN as Special Advisor to the Supervisory Board an ... more

    Nobel Prize for Physiology or Medicine 2019 Announced

    07-Oct-2019 The Nobel Assembly at Karolinska Institutet has decided to award the 2019 Nobel Prize in Physiology or Medicine jointly to William G. Kaelin Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability. Animals need oxygen for th ... more

    ZEISS Opts for Continuity with New CEO

    25-Sep-2019 At its meeting on 24 September 2019, the Supervisory Board of Carl Zeiss AG unanimously voted in favor of the following changes to the Executive Board: Dr. Karl Lamprecht, currently a Member of the Executive Board, will become the new President & CEO effective 1 April 2020. With this appoin ... more

  • Finances

    Sartorius continues on its dynamic growth track

    21-Oct-2019 Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the ye ... more

    €12M Series A Financing to Develop Novel Immuno-Virotherapies Against Cancer

    17-Oct-2019 Abalos Therapeutics announced a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutics based on a specific arenavirus strain that preferentially infects and proliferates in cancer cells gener ... more

    Create blood vessels using patient’s own cells

    Vacis raises capital from Brightlands Venture Partners, HTGF, LIOF and RVO

    14-Oct-2019 Every year, an estimated 300.000 hemodialysis patients worldwide die as they run out of medical alternatives. One of the main reasons for these deaths is failure of the vascular access site, the blood vessel where blood is removed, filtered and returned to the body during dialysis. To solve ... more

  • Cooperation

    CO2 for a clean performance: Rheticus research project by Evonik and Siemens enters phase 2

    High-value specialty chemicals produced from CO2 and water using electricity from renewable sources and bacteria

    14-Oct-2019 Evonik and Siemens launched their joint research project Rheticus II. The goal is to develop an efficient and powerful test plant that will use carbon dioxide and water as well as electricity from renewable sources and bacteria to produce specialty chemicals (CO2). In the Rheticus I project ... more

    Evotec and Celmatix enter into strategic collaboration

    10-Oct-2019 Evotec SE and Celmatix Inc., a precision medicine company with a proprietary multi-omics platform, announced a partnership to develop pre-clinical programmes in prevalent but underserved conditions affecting women’s reproductive health, including polycystic ovary syndrome (“PCOS”), endometr ... more

    ZEISS and Senorics Establish Partnership

    Development of small and cost-effective sensors for industrial use

    09-Oct-2019 ZEISS’ investment in Senorics marks the start of a technology collaboration with the sensorics startup based in Dresden, Germany. The partnership aims to further the joint development of small and cost-effective sensors for industrial use in quality assurance and in process monitoring, e.g. ... more

  • Technology

    Printing nanoparticle shapes for medical applications

    18-Apr-2019 Personal drug delivery or nano-robotic systems could be a key concept for future medical applications. In this context, scientists around David Ng (Department of Prof. Tanja Weil) of the Max Planck Institute for Polymer Research (MPI-P) have recently developed a technology to customize the ... more

    BioMCN to produce renewable methanol with green hydrogen

    27-Feb-2019 Nouryon (formerly AkzoNobel Specialty Chemicals) and Gasunie have agreed to supply green hydrogen to BioMCN for the production of renewable methanol from CO2. The companies say it marks the next step in the sustainability of processes in the industry. Nouryon and Gasunie are currently inves ... more

    Growth factors in single cells counted for the first time

    26-Feb-2019 Whether healthy or diseased, human cells exhibit behaviors and processes that are largely dictated by growth factor molecules, which bind to receptors on the cells. For example, growth factors tell the cells to divide, move, and when to die--a process known as apoptosis. When growth factor ... more

  • Laws

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

  • Market

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

    Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management

    22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more

    Merck announces the winners of its Advance Biotech Grant program

    Merck Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development and Chronic Pain

    31-May-2019 Merck announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center (Massachusetts, U.S.). The grant is given to small- and mid-size biotechnology companies that need funding and expertise to get their thera ... more

  • Politics

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

    15 emerging technologies that could reduce global catastrophic biological risks

    11-Oct-2018 Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Tech ... more

  • Manufacturing

    Eppendorf significantly expands production site in Oldenburg

    27-Sep-2019 The Eppendorf Group is boosting its production capacity at its site in Oldenburg in Holstein by building two new production halls. Operations at the two sites will begin in the second half of 2020, significantly increasing the overall capacity of Eppendorf Polymere GmbH, a wholly owned subs ... more

    Lonza Expands Bioconjugation Facility and Announces Approval of Third Commercial ADC

    24-Jul-2019 Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC) produced at the site. Building on 12 years of experience in the exacting bioconjugation space, Lonza’s expansi ... more

    FUJIFILM Irvine Scientific constructs new cell culture media manufacturing site in Europe

    03-Jul-2019 FUJIFILM Irvine Scientific, Inc. announced plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproducti ... more

  • Career

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

    Lower pension, shorter life

    12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more

    KNAUER among the top one percent of employers in Germany

    28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE